Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: IMPACT OF GERIATRIC ASSESSMENT AND SOMATIC MUTATIONS IN HIGH-RISK MYELODYSPLASTIC SYNDROMES NOT ELIGIBLE FOR ALO-HCST. CET-AZA-2016–1 2022 UPDATE. ON BEHALF OF THE CETLAM GROUP. (May 2023) - Amer, N.; Cabezón, M.; Xicoy, B.; Garrido, A.; Baena, N.; Canet, M.; Arnan, M.; Arenillas, L.; Coll, R.; Ortin, X.; Diaz, M.; Talarn, C.; et al.